Does OBINUTUZUMAB Cause Thrombocytopenia? 889 Reports in FDA Database
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 889 reports of Thrombocytopenia have been filed in association with OBINUTUZUMAB (Gazyva). This represents 6.3% of all adverse event reports for OBINUTUZUMAB.
889
Reports of Thrombocytopenia with OBINUTUZUMAB
6.3%
of all OBINUTUZUMAB reports
77
Deaths
164
Hospitalizations
How Dangerous Is Thrombocytopenia From OBINUTUZUMAB?
Of the 889 reports, 77 (8.7%) resulted in death, 164 (18.4%) required hospitalization, and 44 (4.9%) were considered life-threatening.
Is Thrombocytopenia Listed in the Official Label?
Yes, Thrombocytopenia is listed as a known adverse reaction in the official FDA drug label for OBINUTUZUMAB.
What Other Side Effects Does OBINUTUZUMAB Cause?
Off label use (1,584)
Neutropenia (1,276)
Febrile neutropenia (955)
Covid-19 (942)
Pyrexia (920)
Disease progression (831)
Infusion related reaction (789)
Pneumonia (662)
Anaemia (640)
Atrial fibrillation (548)
What Other Drugs Cause Thrombocytopenia?
DEXAMETHASONE (5,873)
RITUXIMAB (4,810)
CYCLOPHOSPHAMIDE (4,669)
LENALIDOMIDE (4,584)
CARBOPLATIN (4,483)
METHOTREXATE (3,865)
DOXORUBICIN (3,638)
ETOPOSIDE (3,085)
VINCRISTINE (2,940)
OXALIPLATIN (2,886)
Which OBINUTUZUMAB Alternatives Have Lower Thrombocytopenia Risk?
OBINUTUZUMAB vs OCELLA
OBINUTUZUMAB vs OCRELIZUMAB
OBINUTUZUMAB vs OCRIPLASMIN
OBINUTUZUMAB vs OCTINOXATE\OCTISALATE\ZINC
OBINUTUZUMAB vs OCTINOXATE\OCTOCRYLENE